Latest Schedule 13D activist filings

STARTEEPO Invest and Frantisek Bostl report aggregated beneficial ownership of 6.22% in Xerox Holdings Corp following recent share and option transactions.

Graydon Bensler and GB Capital Ltd. jointly file Schedule 13D, reporting a 7.40% stake in PMGC Holdings Inc. through stock and options.

PMGC Holdings Inc. has filed an amendment to its Schedule 13D, detailing beneficial ownership changes and option grants to Northstrive Companies Inc.

Forager Fund, L.P. announced its intention to withhold votes from all directors at Repay Holdings Corp.'s upcoming annual meeting, citing governance concerns and a lack of substantive engagement.

Cevian Capital II GP Ltd has increased its beneficial ownership of Smith & Nephew plc ordinary shares to 11.88%, acquiring over 101 million shares for approximately $1.4 billion.

Wolf Pen Branch, LP and its general partner, Wolf Pen Branch GP, LLC, have amended their Schedule 13D filing to reflect an increased beneficial ownership of Brown-Forman Corporation's Class A Common Stock, now representing 60.3% of the outstanding shares.

Scott M. Pittman amends Schedule 13D regarding Nuo Therapeutics, detailing loan agreements and warrant issuances.

Franklin Resources Inc. and its subsidiary BSP Fund HoldCo report beneficial ownership of 75,000 Class I Shares in Franklin BSP Lending Fund, representing 81.5% of outstanding shares.

Psyence Labs Ltd. has filed a Schedule 13D, revealing beneficial ownership of 1,146,159 common shares, representing 30.05% of Psyence Biomedical Ltd., acquired through a share-for-share exchange.

Star Equity Fund, a significant shareholder, has nominated Rick Coleman for GEE Group's board and called for the removal of two incumbent directors.

Starboard Value LP has reduced its stake in Qorvo to 6.4% after selling 1.9 million shares on June 2, 2026.

NorthStrive Fund II LP and Manager Braeden Lichti have liquidated their entire stake in Bluejay Diagnostics, Inc., marking a complete exit from the company.

Braeden Lichti and Northstrive Fund II LP have filed an exit notice confirming the sale of their entire stake in Bluejay Diagnostics, Inc.

Amtech Systems director Robert Averick has entered into a lock-up agreement in connection with a proposed public offering.

Best Buy founder Richard Schulze has initiated a pre-arranged trading plan for personal estate planning and asset diversification.

Delta Air Lines has entered into a $100 million unsecured term loan agreement with Wheels Up Experience Inc., further solidifying its financial support for the company.

Delta Air Lines has entered into a $100 million unsecured term loan agreement with Wheels Up Experience Inc., further solidifying its financial support for the company.

ADW Capital Partners, L.P. has amended its Schedule 13D filing, reporting an increased beneficial ownership in Compass Diversified Holdings to 19.3% through the purchase and sale of call options.

Mitchell P. Rales has increased his beneficial ownership in ESAB Corporation to 7.1% through the acquisition of Series A Mandatory Convertible Preferred Stock and additional common stock contributions.

Tom Kubota, CEO of Pacific Health Care Organization Inc., has acquired an additional 65,258 shares, increasing his beneficial ownership to 66.3% of the company's common stock.

GG Mars Capital has acquired a significant stake in ZenaTech, Inc. by converting a line of credit and preferred shares into common stock.

IO Biotech, Inc. has ceased operations and filed for Chapter 7 bankruptcy, initiating the liquidation of its assets.

Largest shareholder, Al Shams Investments, urges Braemar's board to call the 2026 Annual Meeting and allow shareholder director elections amidst concerns over Ashford Inc. executive appointments.

Multiple reporting persons have filed an amendment to their Schedule 13D regarding their beneficial ownership of DUKE Robotics Corp. common stock and warrants.

Lee Chong Kuang reports beneficial ownership of 2,041,208 shares, representing 11.3% of Greenpro Capital Corp., following a $50,000 private placement.

GMS Ventures and Investments has invested $5 million in Outlook Therapeutics through a registered direct offering, increasing its beneficial ownership to 22.9%.

Apollo Management and Yahoo Inc. have updated their beneficial ownership in Taboola.com Ltd., now controlling 16.2% of the voting power and 21.1% of total shares.

OrbiMed Advisors and affiliates have increased their beneficial ownership in Q32 Bio Inc. to 17.4% following a recent private placement.

Aperture Sponsor LLC and CEO Calvin Kung have filed a Schedule 13D reporting a 27.1% beneficial ownership stake in Aperture AC following the company's IPO.

Vivek Ramaswamy and Virtuous Industries LLC filed an amendment to their Schedule 13D regarding their ownership stake in Strive, Inc. following share dilution.